Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S, M.R.C.P (UK)
General Physician
MBBS, FCPS (Endocrinology), FCPS (Medicine), SCE Endocrinology (London)
General Physician
MBBS, FCPS (Endocrinology), FCPS (Medicine), SCE Endocrinology (London)
Gastroenterologist
M.B.B.S., M.D (Gastro), MACG(America)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Endocrinologist
MBBS, MSc Diabetes (UK), MSc (Cardiology), Diplomat Endocrinology
Endocrinologist
MBBS, MSc Diabetes (UK), MSc (Cardiology), Diplomat Endocrinology
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Diabetologist
M.B.B.S., DIP DAB
Gastroenterologist
M.B.B.S., F.C.P.S (Gastroenterology)
Diabetologist
M.B.B.S., M.R.C.P (UK), MRCP SCE Endocrinology and diabetes , PG Endocrinology , Certificate for obesity management
Diabetologist
M.B.B.S., M.R.C.P (UK), MRCP SCE Endocrinology and diabetes , PG Endocrinology , Certificate for obesity management
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures